Generic drug companies in no hurry to launch new Covid products

BDR Pharmaceuticals, a Mumbai-based active pharmaceutical ingredient (API) manufacturing company, has developed the API of antiviral pill Paxlovid and can manufacture the drug but it has decided to wait and watch, Shah said. "We will see if there is any need in the country to launch it," he told ET. "At present, cases are mild and are recovering with the conventional treatment."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Uo94Ogb
via IFTTT